Insider Stock Trading History of Langer Robert


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Langer Robert since year 2005. The trader's CIK number is 1239757. At the time of this reporting, Langer Robert is the Director of Bind Therapeutics, Inc . (stock ticker symbol BIND). See this page for all insider trading activities at Bind Therapeutics, Inc .

Note that in the past LANGER ROBERT also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Langer Robert since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-08-26 BIND Bind Therapeutics, Inc Option Ex 15,000 .44 6,600
2013-06-03 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 3.37 8,432
2013-06-04 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 3.90 9,755
2013-06-05 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 3.91 9,775
2013-05-31 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 3.39 8,475
2013-05-30 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 3.40 8,500
2013-05-29 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 3.13 7,825
2013-05-24 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 2.97 7,420
2013-05-28 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 3.03 7,570
2013-05-23 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 2.90 7,250
2013-05-20 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 2.88 7,210
2013-05-22 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 2.89 7,220
2013-05-21 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 2.87 7,180
2013-05-15 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 2.85 7,115
2013-05-16 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 2.84 7,090
2013-05-17 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 2.86 7,157
2013-05-10 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 2.90 7,237
2013-05-13 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 3.00 7,500
2013-05-14 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 2.85 7,125
2013-05-07 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 2.94 7,337
2013-05-08 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 2.86 7,145
2013-05-09 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 2.94 7,337
2013-05-02 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 3.05 7,625
2013-05-03 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 3.02 7,550
2013-05-06 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 3.00 7,510
2013-04-29 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 2.99 7,485
2013-04-30 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 3.19 7,985
2013-05-01 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 3.17 7,920
2013-04-24 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 2.96 7,405
2013-04-25 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 2.94 7,360
2013-04-26 NVIV Invivo Therapeutics Holdings Corp. Sale 2,500 2.85 7,127
2013-01-17 NVIV Invivo Therapeutics Holdings Corp. Sale 52,425 2.46 129,070
2013-01-16 NVIV Invivo Therapeutics Holdings Corp. Sale 102,874 2.46 253,481
2013-01-15 NVIV Invivo Therapeutics Holdings Corp. Sale 35,436 2.47 87,597
2012-06-29 NVIV Invivo Therapeutics Holdings Corp. Sale 24,780 2.31 57,167
2012-07-02 NVIV Invivo Therapeutics Holdings Corp. Sale 20,220 2.39 48,265
2012-06-27 NVIV Invivo Therapeutics Holdings Corp. Sale 13,450 2.40 32,280
2012-06-26 NVIV Invivo Therapeutics Holdings Corp. Sale 126,550 2.42 306,251
2012-06-28 NVIV Invivo Therapeutics Holdings Corp. Sale 15,000 2.30 34,560
2012-04-13 NVIV Invivo Therapeutics Holdings Corp. Sale 40,160 2.39 95,982
2012-04-16 NVIV Invivo Therapeutics Holdings Corp. Sale 159,840 2.40 383,616
2011-12-29 NVIV Invivo Therapeutics Holdings Corp. Sale 165,247 2.49 411,299
2008-08-08 MNTA Momenta Pharmaceuticals Inc Sale 20,000 16.81 336,200
2007-01-30 SONT Sontra Medical Corp Buy 250,000 .10 25,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Langer Robert (Director of Bind Therapeutics, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.